Generic name: fluorometholone and sulfacetamide sodium
Dosage form: Ophthalmic Suspension
Medically reviewed on February 20, 2018.
One drop of FML-S® ophthalmic suspension should be instilled into the conjunctival sac four times daily. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after two days, the patient should be re-evaluated (see PRECAUTIONS).
The dosing of FML-S® ophthalmic suspension may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.
More about FML-S (fluorometholone / sulfacetamide sodium ophthalmic)
- FML-S Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews
- Drug class: ophthalmic steroids with anti-infectives